Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Heart Failure, Congestive, Chronic Heart Failure, Depression
In brief
This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.
Key facts
- Study ID
- NCT00078286
- Run by
- Duke University
- People needed
- 469
- Starts
- 2003-11-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2013-02-27
Who can join
Age: 45 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Chronic heart failure
- Diagnostic and Statistical Manual- Fourth Edition (DSM-IV) criteria for major depression
- Current use of any antipsychotic medication at study entry
You may not qualify if…
- Life-threatening comorbidity with a 50% or higher likelihood of death within 1 year
- History of psychoses, bipolar disorder, or severe personality disorder
- History of alcohol or drug dependence in the last year
- Severe physical disability that may interfere with the study
- Neurological impairment
- Active suicidal ideations
- Current use of antidepressant medication(s) at the start of study medication
Where it is running
- Duke Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.